Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism

Jun Wu, Or Kakhlon, Miguel Weil, Alexander Lossos, Berge A. Minassian*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Abstract

In this Correspondence, B. Minassian and colleagues report that GHF201, an autophagy activator shown to diminish abnormal glycogen aggregates in a mouse model of Adult Polyglucosan Body Disease, fails to reduce such accumulations in a mouse model of Lafora disease. (Figure presented.)

Original languageAmerican English
Pages (from-to)1047-1050
Number of pages4
JournalEMBO Molecular Medicine
Volume16
Issue number5
DOIs
StatePublished - 16 May 2024
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Fingerprint

Dive into the research topics of 'Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism'. Together they form a unique fingerprint.

Cite this